Side-Effect Management

Time From Biopsy to Skin Cancer Surgery Negatively Affected by Patient Perceptions of Delay

By

Vicki Moore, PhD

A survey study explored the effect of patient perception of a delay in skin cancer surgery on time between biopsy and surgery and patient-reported anxiety.

Multidisciplinary Approach Ideal Strategy for Managing Treatment-Related Skin Toxicities

By

Jennifer Larson

Researchers investigated the potential benefits of using a multidisciplinary approach to manage dermatologic effects of monoclonal antibody therapies.

Anti-GPRC5D CAR-T Therapy Elicits Responses After Anti-BCMA CAR Failure

By

Jen Smith

Anti-GPRC5D CAR T-cell therapy can produce responses in patients with relapsed or refractory multiple myeloma, a phase 2 trial suggests.

Tai Ji Quan, Strength Training Not Better Fall Preventives in Postmenopausal Cancer Survivors

By

Jessica Nye, PhD

A randomized, controlled trial compared the effects of participation in tai ji chuan, strength training, and stretching interventions on falls and fall-related injuries in postmenopausal cancer survivors.

Antimicrobial Stewardship Team Improved Use of Carbapenem in Hematology Patients

By

Jessica Nye, PhD

A study sought to determine the effect of an antimicrobial stewardship team on carbapenem therapy in patients with hematologic disorders.

Low Prostate Cancer-Specific Mortality Seen for Men With Localized Disease

Prostate cancer-specific mortality was low for men randomly assigned to active monitoring, prostatectomy, or radiotherapy.

Performance Scores Predict Immune Checkpoint Inhibitor-Related Adverse Events

By

Jessica Nye, PhD

An analysis of data from patients with cancer treated with immune checkpoint inhibitors sought to determine predictors of immune-related adverse effects in these patients.

Recommendation Adherence in Managing ICI-Related Immune-Mediated Adverse Events

By

Vicki Moore, PhD

A study evaluated prescribing practices for management of immune-mediated adverse events with immune checkpoint inhibitor therapy at a hospital system.

CRC Incidence Shifting to Younger Adults, More Advanced Disease

Incidence increased for those younger than 65 years for regional-stage and distant-stage disease since 2010, reversing previous shift to earlier-stage disease.

Vaginal CO₂ Laser Therapy Likely Not Effective for GSM in Breast Cancer Survivors

By

Jessica Nye, PhD

A randomized trial evaluated the effectiveness of CO2 laser for genitourinary syndrome of menopause in breast cancer survivors, compared with sham laser therapy.